Regenxbio (NASDAQ:RGNX) shares gained more than 4% in premarket trading Thursday after investors focused on encouraging clinical trial results for the company’s Duchenne muscular dystrophy therapy, despite weaker-than-expected quarterly financial results. Earnings and Reve
Key Points - Canadian Solar beat first-quarter expectations with revenue of $1.1 billion and gross margin of 25.1%, supported by tariff refund accruals and strong volumes in both solar modules and energy storage. Despite the strong topline, the company still posted a net l
Key Points - Revenue surged in Q1 2026 to $188.9 million, up about 170% year over year, driven mainly by a sharp increase in Bitcoin mining output. Adjusted EBITDA also improved to $14.4 million, though revenue fell sequentially from Q4 due to lower Bitcoin prices and more
Key Points - BioHarvest Sciences reported first-quarter revenue of $8.5 million, up 8% year over year, and kept its 2026 guidance unchanged for both the D2C and CDMO businesses. Cash and deposits rose sharply to $20.2 million from $3.4 million a year earlier. - The company
Key Points - Autolus Therapeutics said first-quarter 2026 product revenue rose to $26.2 million, driven by early traction for AUCATZYL in the U.S. and U.K., and it reaffirmed full-year revenue guidance of $120 million to $135 million. - The company reported a positive gross...</p
Key Points - Anaphylm remains the main focus: Aquestive still plans to resubmit its NDA for the epinephrine sublingual film in Q3 2026, pending FDA feedback on human factors work and other remaining review steps. The company said it has made progress with U.S. and internat
Coles Supermarkets violated consumer law by falsely advertising discounts on 245 products under its Down Down program. An Australian federal court ruled Coles Supermarkets misled shoppers by falsely representing discounts on household products. The case involved 245 items
The firm disclosed a new 213,025-share position in Fastly, valued at $6.19 million at quarter-end March 31, 2026. Carlson Investments initiated a $3.5 million stake in Fastly (FSLY) during the first quarter of 2026, acquiring 213,025 shares. The position grew to $6.19 mill
The customer experience firm pauses its 3% retirement match to redirect $121.1 million in cash flow toward AI and future capabilities. TTEC has paused its 3% 401(k) match for approximately 16,000 U.S. employees, effective immediately, to bolster financial flexibility for A
Even as the market has surged to near all-time highs, plenty of stocks have been left behind in this recent rally. This is particularly true in the consumer space, where tariffs, high gasoline prices, and worries over the state of the consumer persist Nonetheless, t
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.